Stockscreener 앱 받기
10.03
5.80%
0.55
전일 마감가:
$9.48
열려 있는:
$9.66
하루 거래량:
1.75M
Relative Volume:
0.49
시가총액:
$1.06B
수익:
-
순이익/손실:
$-766.97M
주가수익비율:
-1.3094
EPS:
-7.66
순현금흐름:
$-646.43M
1주 성능:
+3.51%
1개월 성능:
-41.69%
6개월 성능:
-33.40%
1년 성능:
-78.37%
1일 변동 폭
$9.5645
$10.18
1주일 범위
$8.92
$10.18
52주 변동 폭
$7.48
$47.42
바이오헤이븐 Stock (BHVN) Company Profile
명칭
Biohaven Ltd
전화
203-404-0410
주소
215 CHURCH STREET, NEW HAVEN, CT
BHVN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BHVN
Biohaven Ltd
|
10.03 | 1.26B | 0 | -766.97M | -646.43M | -7.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
바이오헤이븐 Stock (BHVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-26 | 다운그레이드 | UBS | Buy → Neutral |
| 2025-11-06 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2025-11-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-09-17 | 개시 | Citigroup | Buy |
| 2025-09-03 | 개시 | Raymond James | Strong Buy |
| 2025-05-19 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2024-09-16 | 개시 | Jefferies | Buy |
| 2024-09-04 | 개시 | Bernstein | Outperform |
| 2024-07-24 | 개시 | Morgan Stanley | Overweight |
| 2024-02-16 | 개시 | RBC Capital Mkts | Outperform |
| 2024-02-06 | 개시 | UBS | Buy |
| 2023-12-22 | 개시 | H.C. Wainwright | Buy |
| 2023-12-08 | 개시 | Robert W. Baird | Outperform |
| 2023-01-24 | 개시 | SVB Securities | Outperform |
| 2023-01-04 | 개시 | JP Morgan | Overweight |
| 2022-12-02 | 개시 | BTIG Research | Buy |
| 2022-10-26 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2022-10-12 | 개시 | Piper Sandler | Overweight |
| 2022-08-19 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-08-08 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2022-05-11 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-19 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-08-10 | 다운그레이드 | UBS | Buy → Neutral |
| 2021-08-03 | 재확인 | Canaccord Genuity | Buy |
| 2021-03-11 | 개시 | UBS | Buy |
| 2020-12-15 | 개시 | H.C. Wainwright | Buy |
| 2020-04-17 | 개시 | Cowen | Outperform |
| 2020-02-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-02-06 | 개시 | Mizuho | Buy |
| 2019-11-22 | 개시 | Wedbush | Outperform |
| 2019-06-25 | 재확인 | Canaccord Genuity | Buy |
| 2019-05-06 | 개시 | Goldman | Buy |
| 2019-04-09 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-03-04 | 재확인 | Needham | Buy |
| 2018-07-03 | 재확인 | Needham | Buy |
| 2018-07-02 | 재확인 | Needham | Buy |
| 2018-04-05 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2018-02-22 | 재확인 | Canaccord Genuity | Buy |
| 2017-12-15 | 개시 | Canaccord Genuity | Buy |
| 2017-10-03 | 재확인 | Needham | Buy |
모두보기
바이오헤이븐 주식(BHVN)의 최신 뉴스
Biohaven (BHVN): Assessing Valuation After Recent Share Price Boost - Yahoo! Finance Canada
Why Biohaven Ltd. Common Shares stock is a strong analyst pickCEO Change & Free Expert Verified Stock Movement Alerts - moha.gov.vn
The Bull Case For Biohaven (BHVN) Could Change Following Recent Analyst Downgrades - simplywall.st
Biohaven's Chief Accounting Officer Scooped Up 17,000 Shares. Is the Stock a Buy? - AOL.com
Can Biohaven Ltd. stock outperform in 2025 bull market2025 Market WrapUp & Long Hold Capital Preservation Plans - moha.gov.vn
Biohaven downgraded to Neutral from Buy at UBS - MSN
Understanding the Setup: (BHVN) and Scalable Risk - news.stocktradersdaily.com
UBS Downgrades Biohaven (BHVN) and Lowers Price Target | BHVN St - GuruFocus
UBS downgrades Biohaven stock to Neutral on pipeline setbacks By Investing.com - Investing.com South Africa
UBS Downgrades Biohaven to Neutral From Buy, $11 Price Target - MarketScreener
Cautious Hold Rating on Biohaven Ltd. Amidst R&D Setbacks and Competitive Challenges - TipRanks
UBS downgrades Biohaven stock to Neutral on pipeline setbacks - Investing.com
Jim Cramer on Biohaven: “The Stock Seems Very Low to Me” - MSN
Jim Cramer on Biohaven: "The Stock Seems Very Low to Me" - Finviz
Assessing Biohaven (BHVN) Valuation Following $175 Million Equity Offering and Underwriter Changes - simplywall.st
A Crucial Secondary Offering At Biohaven – Insider Weekends (NYSE:BHVN) - Seeking Alpha
Biohaven Ltd. Reports Q3 2025 Financial Results - MSN
Will Biohaven's (BHVN) $175 Million Equity Raise Reshape Its Path to Financial Strength? - simplywall.st
Biohaven Ltd. (BHVN) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
William Blair Maintains Bullish Stance on Biohaven (BHVN), Sees Robust Operational Growth - MSN
Is Biohaven Ltd. Common Shares stock undervalued historically2025 Performance Recap & Stepwise Trade Execution Plans - newser.com
Biohaven Insiders Bet $33 Million on a Turnaround - MarketBeat
Biohaven price target lowered to $15 from $47 at JPMorgan - TipRanks
How Biohaven Ltd. stock reacts to inflationary pressuresJuly 2025 Market Mood & Target Return Focused Picks - newser.com
Should I buy Biohaven Ltd. Common Shares stock before earnings season2025 EndofYear Setup & Intraday High Probability Alerts - newser.com
How Biohaven Ltd. stock benefits from global expansionAnalyst Upgrade & Technical Pattern Based Signals - newser.com
Can Biohaven Ltd. Common Shares stock sustain double digit ROEJuly 2025 Fed Impact & AI Driven Price Forecasts - newser.com
Is Biohaven Ltd. stock vulnerable to regulatory risks2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
Why hedge funds are buying Biohaven Ltd. stockQuarterly Portfolio Review & High Conviction Trade Alerts - newser.com
What MACD trends signal for Biohaven Ltd. Common Shares stockPortfolio Profit Report & High Win Rate Trade Alerts - newser.com
What Fibonacci levels say about Biohaven Ltd. reboundWeekly Loss Report & Free Long-Term Investment Growth Plans - newser.com
Building trade automation scripts for Biohaven Ltd.2025 Volume Leaders & Free High Return Stock Watch Alerts - newser.com
Why Biohaven Ltd. stock is favored by pension fundsQuarterly Performance Summary & Fast Moving Market Watchlists - newser.com
Signal strength of Biohaven Ltd. stock in tech scanners2025 Top Gainers & Risk Controlled Daily Trade Plans - newser.com
Can Biohaven Ltd. stock resist sector downturnsJuly 2025 Recap & Pattern Based Trade Signal System - newser.com
Has Biohaven Ltd. formed a bullish divergenceJuly 2025 Chart Watch & Low Drawdown Investment Ideas - newser.com
Market reaction to Biohaven Ltd.’s recent newsQuarterly Trade Review & Free Accurate Trade Setup Notifications - newser.com
Independent Director of Biohaven John Childs Buys 52% More Shares - simplywall.st
바이오헤이븐 (BHVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.45%
1.13%
자본화:
|
볼륨(24시간):